Continuing Education Event – Best Practices in Substance Use Disorder Treatment: Development, Delivery and Evaluation – Webinar – 7/23/2020
The United States is in the midst an addiction crisis. The treatment field and the public have been increasingly viewing addiction as a chronic medical illness in the past 5-10 years, however, our approach to treatment delivery and measurement have not reflected these changes. The Institute of Medicine has specifically called for greater development, implementation, and measurement of evidence-based practices (EBPs) but ensuring adequate adherence and competence in clinical delivery of these practices has lagged. Here we look at the development, delivery, and measurement of EPBs in addiction treatment. We examine the role of stigma, the evidence that addiction is a chronic medical illness, and the results of clinically based research on current treatment available for drug and alcohol dependence. We look at the measurement of “success” in treatment including benefits to multiple stakeholders: patients and families, insurers, other healthcare providers, the criminal justice system etc. We provide an argument against the most commonly used measure of success – “total abstinence” as the sole or most important measure in the field and discuss how that came about and the damage it does to the field. Addiction treatment providers who want to survive and thrive will have to join this revolution in delivering evidence-based practices along a full continuum of care and showing accountability through data aggregation, transparency, and outcome measurement.
• Recognize the best “evidence-based practices” from among the myriad of available services and practices
• Identify key factors in a full continuum of care.
• Learn how to evaluate if a program is delivering practices with fidelity to ensure best chances at success.
• Know the top components to look for when selecting substance abuse treatment programs.
• Describe potential tools and instruments and curriculum that can be used for EBP and MBC in the behavioral health field
Recovery Centers of America has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7002. Programs that do not qualify for NBCC credit are clearly identified. Recovery Centers of America is solely responsible for all aspects of the programs. This course qualifies for 1 credit hour.
Deni Carise, Ph.D.
Chief Scientific Officer
Deni Carise, Ph.D. is a Clinical Psychologist and part of the recovery community for over 30 years. She is currently Chief Scientific Officer of Recovery Centers of America (RCA) and Adjunct Assistant Professor at University of Pennsylvania. RCA is dedicated to creating neighborhood-based treatment and recovery campuses that include detoxification, residential, partial hospital, intensive and traditional outpatient, and family services, all available on one campus. Beginning in March 2016, they opened 6 such campuses, 2 in MA and MD, and 1 each in PA and NJ, multiple outpatient programs and one opioid treatment program. Their goal is to get 1 million Americans into meaningful recovery.
Deni has held similar positions at CRC Health Group, providing behavioral health services to more than 42,000 men, women and teens every day at more than140 programs in 33 states and Phoenix House, a nonprofit substance abuse treatment provider with over 100 programs in 10 states where Dr Carise developed national standards for clinical care, Clinical Toolkits for over 30 evidence-based practices, and helped usher in a new era of care to position the company to successfully address changes secondary to healthcare reform. Dr Carise was also Chief Clinical Advisor for Sierra Tucson, a premier facility treating substance abuse, pain, mood, eating and trauma disorders.